Home-based Extended Rehabilitation for Older people (HERO): study protocol for an individually randomised controlled multi-centre trial to determine the clinical and cost-effectiveness of a home-based exercise intervention for older people with frailty as extended rehabilitation following acute illness or injury, including embedded process evaluation
dc.contributor.author | Prescott, M | |
dc.contributor.author | Lilley-Kelly, A | |
dc.contributor.author | Cundill, B | |
dc.contributor.author | Clarke, D | |
dc.contributor.author | Drake, S | |
dc.contributor.author | Farrin, AJ | |
dc.contributor.author | Forster, A | |
dc.contributor.author | Goodwin, M | |
dc.contributor.author | Goodwin, VA | |
dc.contributor.author | Hall, AJ | |
dc.contributor.author | Hartley, S | |
dc.contributor.author | Holland, M | |
dc.contributor.author | Hulme, C | |
dc.contributor.author | Nikolova, S | |
dc.contributor.author | Parker, C | |
dc.contributor.author | Wright, P | |
dc.contributor.author | Ziegler, F | |
dc.contributor.author | Clegg, A | |
dc.date.accessioned | 2021-11-10T13:50:04Z | |
dc.date.issued | 2021-11-08 | |
dc.date.updated | 2021-11-10T10:51:19Z | |
dc.description.abstract | Background The majority of older people (> 65 years) in hospital have frailty and are at increased risk of readmission or death following discharge home. In the UK, following acute hospitalisation, around one third of older people with frailty are referred on for rehabilitation, termed ‘intermediate care’ services. Although this rehabilitation can reduce early readmission to hospital (< 30 days), recipients often do not feel ready to leave the service on discharge, suggesting possible incomplete recovery. Limited evidence suggests extended rehabilitation is of benefit in several conditions and there is preliminary evidence that progressive physical exercise can improve mobility and function for older people with frailty, and slow progression to disability. Our aim is to evaluate the effectiveness of the Home-based Older People’s Exercise (HOPE) programme as extended rehabilitation for older people with frailty discharged home from hospital or intermediate care services after acute illness or injury. Methods A multi-centre individually randomised controlled trial, to evaluate the clinical and cost-effectiveness of the HOPE programme. This individualised, graded and progressive 24-week exercise programme is delivered by NHS physiotherapy teams to people aged 65 and older with frailty, identified using the Clinical Frailty Scale, following discharge from acute hospitalisation and linked intermediate care rehabilitation pathways. The primary outcome is physical health-related quality of life, measured using the physical component summary score of the modified Short Form 36- item health questionnaire (SF36) at 12 months. Secondary outcomes include self-reported physical and mental health, functional independence, death, hospitalisations, care home admissions. Plans include health economic analyses and an embedded process evaluation. Discussion This trial seeks to determine if extended rehabilitation, via the HOPE programme, can improve physical health-related quality of life for older people with frailty following acute hospitalisation. Results will improve awareness of the rehabilitation needs of older people with frailty, and provide evidence on the clinical and cost-effectiveness of the targeted exercise intervention. There is potential for considerable benefit for health and social care services through widespread implementation of trial findings if clinical and cost-effectiveness is demonstrated. | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.identifier.citation | Vol. 22, No. 1, article 783 | en_GB |
dc.identifier.doi | https://doi.org/10.1186/s13063-021-05778-5 | |
dc.identifier.grantnumber | 15/47/07 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/127750 | |
dc.identifier | ORCID: 0000-0003-3860-9607 (Goodwin, Victoria A) | |
dc.language.iso | en | en_GB |
dc.publisher | BMC | en_GB |
dc.rights | © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | en_GB |
dc.subject | Older people | en_GB |
dc.subject | frailty | en_GB |
dc.subject | Ageing | en_GB |
dc.subject | Randomised controlled trial | en_GB |
dc.subject | Exercise | en_GB |
dc.subject | Physiotherapy | en_GB |
dc.subject | Rehabilitation | en_GB |
dc.subject | Quality of life | en_GB |
dc.subject | Protocol | en_GB |
dc.subject | Process evaluation | en_GB |
dc.subject | Partially nested | en_GB |
dc.subject | Behaviour change | en_GB |
dc.subject | Complex intervention | en_GB |
dc.title | Home-based Extended Rehabilitation for Older people (HERO): study protocol for an individually randomised controlled multi-centre trial to determine the clinical and cost-effectiveness of a home-based exercise intervention for older people with frailty as extended rehabilitation following acute illness or injury, including embedded process evaluation | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2021-11-10T13:50:04Z | |
exeter.article-number | 783 | |
dc.description | This is the final version. Available from BMC via the DOI in this record. | en_GB |
dc.description | Bradford Teaching Hospitals NHS Foundation Trust will be the Data Controller for the trial. The CTRU University of Leeds are the Data Custodians. Reasonable requests for access to the final trial dataset will be considered and should be submitted in writing to A.P.Clegg@leeds.ac.uk. | en_GB |
dc.identifier.eissn | 1745-6215 | |
dc.identifier.journal | Trials | en_GB |
dc.relation.ispartof | Trials, 22(1) | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2021-10-29 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2021-11-08 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2021-11-10T13:47:28Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2021-11-10T13:50:09Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2021-11-08 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.